Evidence map›Paper›PMID 9298711›Full record

ArticleJournal of bioenergetics and biomembranes1997

Plasma membrane ubiquinone controls ceramide production and prevents cell death induced by serum withdrawal.

M P Barroso, C Gómez-Díaz, J M Villalba, M I Burón, G López-Lluch, P Navas

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of bioenergetics and biomembranes, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 78 citations in OpenAlex.

  1. Trial
  2. Article
  3. Levels of Plasma Coenzyme QAntioxidants (Basel, Switzerland) · 2022
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Calorie restriction up-regulates the plasma membrane redox system in brain cells and suppresses oxidative stress during aging.Proceedings of the National Academy of Sciences of the United States of America · 2006
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

M P BarrosoDepartamento de Biología Celular, Facultad de Ciencias, Universidad de Córdoba, Spain.
C Gómez-Díaz
J M Villalba
M I Burón
G López-Lluch
P Navas
University of Córdoba · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serum provides cultured cells with survival factors required to maintain growth. Its withdrawal induces the development of programmed cell death. HL-60 cells were sensitive to serum removal, and an increase of lipid peroxidation and apoptosis was observed. Long-term treatment with ethidium bromide induced the mitochondria-deficient rho(o)HL-60 cell line. These cells were surprisingly more resistant to serum removal, displaying fewer apoptotic cells and lower lipid peroxidation. HL-60 cells contained less ubiquinone at the plasma membrane than rho(o)HL-60 cells. Both cell types increased plasma membrane ubiquinone in response to serum removal, although this increase was much higher in rho(o) cells. Addition of ubiquinone to both cell cultures in the absence of serum improved cell survival with decreasing lipid peroxidation and apoptosis. Ceramide was accumulated after serum removal in HL-60 but not in rho(o)HL-60 cells, and exogenous ubiquinone reduced this accumulation. These results demonstrate a relationship between ubiquinone levels in the plasma membrane and the induction of serum withdrawal-induced apoptosis, and ceramide accumulation. Thus, ubiquinone, which is a central component of the plasma membrane electron transport system, can represent a first level of protection against oxidative damage caused by serum withdrawal.

Indexed as

ApoptosisCell MembraneCeramidesCulture Media, Serum-FreeCytosolDNA, MitochondrialDNA ReplicationEnzyme InhibitorsEthidiumHL-60 CellsHumansLipid PeroxidesUbiquinoneCeramidesCulture Media, Serum-FreeDNA, MitochondrialEnzyme InhibitorsEthidiumLipid PeroxidesUbiquinone

Identifiers

PMID9298711
OpenAlexW172604253

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.